Evotec SE (EVO) Short-term Investments (2020 - 2026)
Evotec SE's (EVO) quarterly Short-term Investments came in at $66558.1 in Q1 2026, down 26.48% year-on-year from $90531.5 in Q1 2025, and down 1.2% quarter-over-quarter from $67366.7 in Q4 2025.
Evotec SE (EVO) Short-term Investments (2020 - 2026) Analysis & Trends
Evotec SE has disclosed Short-term Investments across 7 years of filings, most recently posting $66558.1 for Q1 2026.
- Short-term Investments for Q1 2026 came in at $66558.1, down 26.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $66558.1 (down 26.48% YoY), and the FY2025 annual result was $67366.7, down 99.93% from the prior year.
- Short-term Investments came in at $66558.1 for Q1 2026 at Evotec SE, down from $67366.7 in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $309.5 million in Q4 2022 to a low of $66558.1 in Q1 2026.
- The 5-year median for Short-term Investments is $90756.0 (2025), against an average of $39.1 million.
- Across the five-year window, Short-term Investments surged 265.43% in 2022 and plunged 99.93% in 2025, its largest moves.
- Evotec SE's Short-term Investments stood at $309.5 million in 2022, then plunged by 67.6% to $100.3 million in 2023, then slipped by 3.66% to $96.6 million in 2024, then slumped by 99.93% to $67366.7 in 2025, then dropped by 1.2% to $66558.1 in 2026.
- The last three Short-term Investments figures came in at $66558.1 (Q1 2026), $67366.7 (Q4 2025), and $73919.4 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Evotec SE | 583.10 Mn | 582.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66,558.06 |
| Dec 31, 2025 | 67,366.69 |
| Sep 30, 2025 | 73,919.35 |
| Jun 30, 2025 | 90,756.00 |
| Mar 31, 2025 | 90,531.49 |
| Dec 31, 2024 | 96.61 Mn |
| Sep 30, 2024 | 82,635.53 |
| Mar 31, 2024 | 88,680.80 |
| Dec 31, 2023 | 100.28 Mn |
| Dec 31, 2022 | 309.48 Mn |
| Sep 30, 2022 | 362,731.73 |
| Jun 30, 2022 | 203,687.25 |
| Mar 31, 2022 | 218,101.64 |
| Dec 31, 2021 | 181.79 Mn |
| Sep 30, 2021 | 99,261.79 |
| Dec 31, 2020 | 12.76 Mn |